• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多个位点的微卫星不稳定性与晚期胃癌长期生存的相关性

Correlation of microsatellite instability at multiple loci with long-term survival in advanced gastric carcinoma.

作者信息

Corso Giovanni, Pedrazzani Corrado, Marrelli Daniele, Pascale Valeria, Pinto Enrico, Roviello Franco

机构信息

Sezione di Chirurgia Oncologica, Dipartimento di Patologia Umana e Oncologia, Policlinico Le Scotte, University of Siena, 53100 Siena, Italy.

出版信息

Arch Surg. 2009 Aug;144(8):722-7. doi: 10.1001/archsurg.2009.42.

DOI:10.1001/archsurg.2009.42
PMID:19687375
Abstract

HYPOTHESIS

Microsatellite instability (MSI) correlates with clinicopathologic characteristics and long-term prognosis in patients having gastric carcinoma.

DESIGN

Analysis of prospectively collected data and biologic material.

SETTING

Tertiary University Hospital, Policlinico "Le Scotte," Siena, Italy.

PATIENTS

Two hundred fifty patients with gastric carcinoma.

MAIN OUTCOME MEASURES

Five mononucleotide repeats (BAT-26, BAT-25, NR-24, NR-21, and NR-27) were analyzed in these patients.

RESULTS

An MSI phenotype was identified in 63 patients (25.2%) and correlated with specific clinicopathologic characteristics. Favorable prognosis was confirmed for patients with an MSI phenotype in univariate (P < .001) and multivariate (P = .05) analyses. Significant differences in clinicopathologic characteristics and long-term prognoses were observed among patients with microsatellite-stable tumors, tumors having instability at 2 to 4 markers, and tumors having instability at all 5 markers (MSI/5). The MSI/5 phenotype was associated with older age (P < .001), female sex (P = .001), antral tumor location (P = .04), intestinal histotype (P = .003), and less infiltration of the serosa (P = .006); lymph node involvement was rare (P < .001) and was limited to few (median, 3) metastatic lymph nodes (P = .001). Long-term survival of patients with the MSI/5 phenotype is favorable and was confirmed in multivariate analysis (relative risk vs patients with stable tumors, 0.32; 95% confidence interval, 0.16-0.63; P = .002).

CONCLUSIONS

Compared with stable tumors, MSI tumors have distinct clinicopathologic features and are associated with a better prognosis. Patients with the MSI/5 phenotype have a very good prognosis.

摘要

假设

微卫星不稳定性(MSI)与胃癌患者的临床病理特征及长期预后相关。

设计

对前瞻性收集的数据和生物材料进行分析。

地点

意大利锡耶纳大学综合医院“Le Scotte”三级大学医院。

患者

250例胃癌患者。

主要观察指标

分析这些患者的五个单核苷酸重复序列(BAT-26、BAT-25、NR-24、NR-21和NR-27)。

结果

63例患者(25.2%)被鉴定为MSI表型,且与特定临床病理特征相关。单因素分析(P <.001)和多因素分析(P =.05)均证实MSI表型患者预后良好。微卫星稳定肿瘤患者、2至4个标记不稳定的肿瘤患者和所有5个标记均不稳定的肿瘤(MSI/5)患者在临床病理特征和长期预后方面存在显著差异。MSI/5表型与年龄较大(P <.001)、女性(P =.001)、胃窦部肿瘤位置(P =.04)、肠型组织学(P =.003)及浆膜浸润较少(P =.006)相关;淋巴结受累罕见(P <.001),且局限于少数(中位数为3个)转移淋巴结(P =.001)。MSI/5表型患者的长期生存率良好,多因素分析证实了这一点(与稳定肿瘤患者相比,相对风险为0.32;95%置信区间为0.16 - 0.63;P =.002)。

结论

与稳定肿瘤相比,MSI肿瘤具有独特的临床病理特征,且预后较好。MSI/5表型患者预后非常好。

相似文献

1
Correlation of microsatellite instability at multiple loci with long-term survival in advanced gastric carcinoma.多个位点的微卫星不稳定性与晚期胃癌长期生存的相关性
Arch Surg. 2009 Aug;144(8):722-7. doi: 10.1001/archsurg.2009.42.
2
Microsatellite instability in gastric cancer is associated with tumor location and family history in a high-risk population from Tuscany.在托斯卡纳的一个高危人群中,胃癌的微卫星不稳定性与肿瘤位置和家族史相关。
Cancer Res. 1997 Oct 15;57(20):4523-9.
3
Microsatellite instability in gastric cancer is associated with better prognosis in only stage II cancers.胃癌中的微卫星不稳定性仅与II期癌症的较好预后相关。
Surgery. 2006 Mar;139(3):347-56. doi: 10.1016/j.surg.2005.08.021.
4
Strong Prognostic Value of Microsatellite Instability in Intestinal Type Non-cardia Gastric Cancer.微卫星不稳定性在肠型非贲门胃癌中的强大预后价值
Ann Surg Oncol. 2016 Mar;23(3):943-50. doi: 10.1245/s10434-015-4931-3. Epub 2015 Nov 3.
5
Microsatellite instability and DNA ploidy in colorectal cancer: potential implications for patients undergoing systematic surveillance after resection.结直肠癌中的微卫星不稳定性和DNA倍性:对切除术后接受系统监测的患者的潜在影响
Cancer. 2009 Jan 15;115(2):271-82. doi: 10.1002/cncr.24024.
6
Chemosensitivity and survival in gastric cancer patients with microsatellite instability.微卫星不稳定的胃癌患者的化疗敏感性与生存率
Ann Surg Oncol. 2009 Sep;16(9):2510-5. doi: 10.1245/s10434-009-0580-8. Epub 2009 Jun 30.
7
Genetic changes in Slovenian patients with gastric adenocarcinoma evaluated in terms of microsatellite DNA.根据微卫星DNA评估斯洛文尼亚胃腺癌患者的基因变化。
Eur J Gastroenterol Hepatol. 2007 Dec;19(12):1082-9. doi: 10.1097/MEG.0b013e3282f13cf9.
8
Gastric cancer with high-level microsatellite instability: target gene mutations, clinicopathologic features, and long-term survival.具有高度微卫星不稳定性的胃癌:靶基因突变、临床病理特征及长期生存情况
Hum Pathol. 2008 Jun;39(6):925-32. doi: 10.1016/j.humpath.2007.10.024. Epub 2008 Apr 28.
9
Alterations of BAT-26 identify a subset of gastric cancer with distinct clinicopathologic features and better postoperative prognosis.BAT-26的改变可识别出具有独特临床病理特征且术后预后较好的一部分胃癌。
Hepatogastroenterology. 2002 Jan-Feb;49(43):285-9.
10
High microsatellite instability predicts good prognosis in intestinal-type gastric cancers.高度微卫星不稳定预示着肠型胃癌的良好预后。
J Gastroenterol Hepatol. 2011 Mar;26(3):585-92. doi: 10.1111/j.1440-1746.2010.06487.x.

引用本文的文献

1
Potent therapeutic strategy in gastric cancer with microsatellite instability-high and/or deficient mismatch repair.具有微卫星不稳定高和/或错配修复缺陷的胃癌的有效治疗策略。
Gastric Cancer. 2024 Sep;27(5):907-931. doi: 10.1007/s10120-024-01523-4. Epub 2024 Jun 26.
2
Clinical and Genetic Characteristics of Early and Advanced Gastric Cancer.早期和进展期胃癌的临床及遗传学特征
Curr Issues Mol Biol. 2024 Feb 1;46(2):1208-1218. doi: 10.3390/cimb46020077.
3
Microsatellite instability in gastrointestinal cancers.胃肠道癌症中的微卫星不稳定性
Eur J Hum Genet. 2022 Sep;30(9):996-997. doi: 10.1038/s41431-022-01134-6. Epub 2022 Jun 21.
4
Recent insights into the use of immune checkpoint inhibitors in gastric cancer.免疫检查点抑制剂在胃癌治疗中的最新见解。
Porto Biomed J. 2022 Feb 8;7(1):e162. doi: 10.1097/j.pbj.0000000000000162. eCollection 2022 Mar-Apr.
5
The Impact of Mismatch Repair Status on Prognosis of Patients With Gastric Cancer: A Multicenter Analysis.错配修复状态对胃癌患者预后的影响:一项多中心分析
Front Oncol. 2021 Nov 25;11:712760. doi: 10.3389/fonc.2021.712760. eCollection 2021.
6
Clinical characteristics and responses to chemotherapy and immune checkpoint inhibitor treatment for microsatellite instability gastric cancer.微卫星不稳定型胃癌的临床特征及对化疗和免疫检查点抑制剂治疗的反应
Am J Cancer Res. 2020 Dec 1;10(12):4123-4133. eCollection 2020.
7
Finding the hot spot: identifying immune sensitive gastrointestinal tumors.寻找热点:识别免疫敏感的胃肠道肿瘤。
Transl Gastroenterol Hepatol. 2020 Oct 5;5:48. doi: 10.21037/tgh.2019.12.11. eCollection 2020.
8
The Clinicopathological Features and Genetic Mutations in Gastric Cancer Patients According to EMAST and MSI Status.根据EMAST和MSI状态分析胃癌患者的临床病理特征及基因突变
Cancers (Basel). 2020 Feb 27;12(3):551. doi: 10.3390/cancers12030551.
9
Novel Biomarkers for Prediction of Response to Preoperative Systemic Therapies in Gastric Cancer.预测胃癌术前全身治疗反应的新型生物标志物
J Gastric Cancer. 2019 Dec;19(4):375-392. doi: 10.5230/jgc.2019.19.e39. Epub 2019 Nov 13.
10
Integrated assessment of PD-L1 expression and molecular classification facilitates therapy selection and prognosis prediction in gastric cancer.PD-L1表达与分子分类的综合评估有助于胃癌的治疗选择和预后预测。
Cancer Manag Res. 2019 Jul 10;11:6397-6410. doi: 10.2147/CMAR.S206189. eCollection 2019.